These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33482711)

  • 1. Vasoplegia in patients following ventricular assist device explant and heart transplantation.
    Emmanuel S; Pearman M; Jansz P; Hayward CS
    Perfusion; 2022 Mar; 37(2):152-161. PubMed ID: 33482711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoplegia from Continuous Flow Left Ventricular Assist Devices.
    Sathianathan S; Bhat G; Dowling R
    Curr Cardiol Rep; 2021 Jul; 23(8):101. PubMed ID: 34196837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
    Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H
    ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.
    Haglund NA; Feurer ID; Ahmad RM; DiSalvo TG; Lenihan DJ; Keebler ME; Schlendorf KH; Stulak JM; Wigger MA; Maltais S
    J Heart Lung Transplant; 2014 Sep; 33(9):931-6. PubMed ID: 24925183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.
    Batchelor RJ; Wong N; Liu DH; Chua C; William J; Tee SL; Sata Y; Bergin P; Hare J; Leet A; Taylor AJ; Patel HC; Burrell A; McGiffin D; Kaye DM
    J Card Fail; 2022 Apr; 28(4):617-626. PubMed ID: 34974975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device.
    Sacks LD; Hollander SA; Zhang Y; Ryan KR; Ford MA; Maeda K; Murray JM; Almond CS; Kwiatkowski DM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2433-2440. PubMed ID: 30929985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right Ventricular Failure After Left Ventricular Assist Device Placement-The Beginning of the End or Just Another Challenge?
    Turner KR
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1105-1121. PubMed ID: 30197170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoplegia following heart transplantation and left ventricular assist device explant is not associated with inferior outcomes.
    Ali JM; Patel S; Catarino P; Vuylsteke A; Pettit S; Bhagra S; Kydd A; Lewis C; Parameshwar J; Kaul P; Sudarshan C; Tsui S; Jenkins D; Abu-Omar Y; Berman M
    J Thorac Dis; 2020 May; 12(5):2426-2434. PubMed ID: 32642148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
    Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.
    de Waal EEC; van Zaane B; van der Schoot MM; Huisman A; Ramjankhan F; van Klei WA; Marczin N
    BMC Anesthesiol; 2018 Dec; 18(1):185. PubMed ID: 30526494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARNI Pre-Operative Use and Vasoplegic Syndrome in Patients Undergoing Heart Transplantation or Left Ventricular Assist Device Surgery.
    Haider L; Hugon-Vallet E; Constantin JP; Riad Z; Sebbag L; Mewton N
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076588
    [No Abstract]   [Full Text] [Related]  

  • 16. Redo sternotomy versus left ventricular assist device explant as risk factors for early mortality following heart transplantation.
    Ribeiro RVP; Alvarez JS; Fukunaga N; Yu F; Adamson MB; Foroutan F; Cusimano RJ; Yau T; Ross H; Alba AC; Billia F; Badiwala MV; Rao V
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):603-610. PubMed ID: 33137824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
    Patarroyo M; Simbaqueba C; Shrestha K; Starling RC; Smedira N; Tang WH; Taylor DO
    J Heart Lung Transplant; 2012 Mar; 31(3):282-7. PubMed ID: 22112993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.